Table of Contents Author Guidelines Submit a Manuscript
Multiple Sclerosis International
Volume 2016 (2016), Article ID 1034912, 8 pages
http://dx.doi.org/10.1155/2016/1034912
Review Article

Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks

1Division of Neurology, Amiri Hospital and Division of Neurology, Dasman Diabetes Institute, Dasman, Kuwait
2Division of Neurology, Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey
3King Abdullah International Medical Research Center, King Saud Ben Abdulaziz University for Health Sciences, NGHA, Riyadh, Saudi Arabia
4KFMC, Ministry of Health, Riyadh, Saudi Arabia
5MS Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
6Clinical Neurosciences Department, Salmaniya Medical Complex, Manama, Bahrain
7Neurology Section, King Khalid University Hospital, King Saud University and Dallah Hospital, Riyadh, Saudi Arabia
8King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
9Department of Internal Medicine, Neurology Section, Arab Medical Center and Khalidi Hospital, Amman, Jordan
10Department of Neurology (Medicine), Hamad Medical Corporation, Doha, Qatar
11Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain
12Laboratory of Experimental Neurology and Neuroimmunology, Multiple Sclerosis Center, 2nd Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
13Neurology Department, Rashid Hospital and Dubai Medical College, Dubai Health Authority, Dubai, UAE
14Department of Neurology, Neuroimmunology Unit, Hacettepe University Hospitals, Ankara, Turkey
15Merck, Intercontinental Region, Dubai, UAE
16Department of Neurology, 1st St. Petersburg State Medical University n.a. I.P. Pavlov, St. Petersburg, Russia
17Multiple Sclerosis Center, American University of Beirut Medical Center, Beirut, Lebanon
18Faculty of Medicine, Ain Shams University, Cairo, Egypt
19Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Received 5 August 2016; Accepted 14 November 2016

Academic Editor: Mauro Zaffaroni

Copyright © 2016 Raed Alroughani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Raed Alroughani, Ayse Altintas, Mohammed Al Jumah, et al., “Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks,” Multiple Sclerosis International, vol. 2016, Article ID 1034912, 8 pages, 2016. doi:10.1155/2016/1034912